Allan Grey prefers South African stocks over bonds
Allan Gray, one of South Africa’s largest asset managers, believes that South African equities are a better investment than bonds for investors, despite the country’s challenges. Some stocks on the JSE are enticingly valued, making Allan Gray bullish on South African equities. Read the full article on Bloomberg.
Aspen contracted by Novo Nordisk to manufacture insulin for the Africa market
Africa’s largest drug maker Aspen Pharmacare is partnering with Danish healthcare firm Novo Nordisk to establish SA’s first production of human insulin. This could have a significant impact on healthcare in South Africa and the rest of Africa, as it would make human insulin more accessible and affordable. Read the full article on Reuters.